1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Institutional indications for MR-VWI performance relative to ordering provider interest
Ordered by Research Atheroma Risk Aneurysm Risk Differentiate Vasculopathy Cryptogenic Stroke Neurology only (n = 97) (No.) (%) 12 (12.4) 24 (24.7) 11 (11.3) 69 (71.1) 32 (33.0) Neurology and neurosurgery (n = 60) (No.) (%) 16 (26.7) 25 (41.7) 36 (60) 50 (83.3) 23 (38.3) Neurology, neurosurgery, and rheumatology (n = 26) (No.) (%) 15 (57.7) 10 (38.5) 15 (57.7) 21 (80.8) 13 (50) Neurosurgery only (n = 5) (3 blank for reasons) (No.) (%) 1 (20) 0 (0) 1 (20) 2 (40) 1 (20)